Morgan Stanley analyst Aisyah Noor raised the firm’s price target on Medacta Group (MEDGF) to CHF 136 from CHF 135 and keeps an Overweight rating on the shares.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDGF: